XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Segment Reporting

12.  Segment Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses. Among other measures, we assess and measure segment operating results based on net income from continuing operations attributable to Icahn Enterprises. Certain terms of financings for certain of our businesses impose restrictions on the business’ ability to transfer funds to us, including restrictions on dividends, distributions, loans and other transactions.

Condensed Statements of Operations

Three Months Ended March 31, 2022

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Metals

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

2,373

$

407

$

101

$

17

$

55

$

15

$

$

$

2,968

Other revenues from operations

 

 

 

147

 

 

11

 

 

1

 

 

 

159

Net gain from investment activities

 

908

 

 

 

 

 

 

 

 

31

 

939

Interest and dividend income

 

40

 

 

 

 

 

 

 

 

2

 

42

Other (loss) income, net

 

(17)

 

(10)

 

2

 

1

 

 

 

1

 

 

(1)

 

(24)

 

931

 

2,363

 

556

 

102

 

28

 

55

 

17

 

 

32

 

4,084

Expenses:

Cost of goods sold

 

 

2,123

 

267

 

81

 

10

 

45

 

12

 

 

 

2,538

Other expenses from operations

 

 

 

117

 

 

11

 

 

 

 

 

128

Selling, general and administrative

 

4

 

45

 

208

 

13

 

4

 

11

 

10

 

 

6

 

301

Interest expense

 

32

 

24

 

1

 

1

 

 

 

 

 

76

 

134

 

36

 

2,192

 

593

 

95

 

25

 

56

 

22

 

 

82

 

3,101

Income (loss) before income tax benefit (expense)

 

895

 

171

 

(37)

 

7

 

3

 

(1)

 

(5)

 

 

(50)

 

983

Income tax expense

 

 

(30)

 

9

 

(1)

 

 

 

 

 

(76)

 

(98)

Net income (loss)

 

895

 

141

 

(28)

 

6

 

3

 

(1)

 

(5)

 

 

(126)

 

885

Less: net income (loss) attributable to non-controlling interests

 

481

 

80

 

 

1

 

 

 

 

 

 

562

Net income (loss) attributable to Icahn Enterprises

$

414

$

61

$

(28)

$

5

$

3

$

(1)

$

(5)

$

$

(126)

$

323

Supplemental information:

Capital expenditures

$

$

26

$

21

$

4

$

4

$

$

$

$

$

55

Depreciation and amortization

$

$

83

$

20

$

7

$

3

$

2

$

7

$

$

$

122

Three Months Ended March 31, 2021

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Metals

    

Holding Company

 

Consolidated

(in millions)

 

Revenues:

    

  

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

1,463

$

456

$

101

$

8

$

41

$

29

$

120

$

$

2,218

Other revenues from operations

 

 

 

142

 

 

9

 

 

1

 

 

 

152

Net gain from investment activities

 

939

 

62

 

 

 

 

 

 

 

5

 

1,006

Interest and dividend income

 

25

 

 

 

 

 

 

 

 

1

 

26

Other (loss) income, net

 

(21)

 

7

 

(1)

 

(6)

 

 

 

 

1

 

2

 

(18)

 

943

 

1,532

 

597

 

95

 

17

 

41

 

30

 

121

 

8

 

3,384

Expenses:

 

Cost of goods sold

 

 

1,579

 

313

 

80

 

7

 

34

 

14

 

112

 

 

2,139

Other expenses from operations

 

 

 

112

 

 

6

 

 

 

 

 

118

Selling, general and administrative

 

5

 

35

 

227

 

13

 

5

 

11

 

8

 

4

 

8

 

316

Interest expense

 

76

 

31

 

3

 

2

 

 

 

 

 

83

 

195

 

81

 

1,645

 

655

 

95

 

18

 

45

 

22

 

116

 

91

 

2,768

Income (loss) before income tax benefit (expense)

 

862

 

(113)

 

(58)

 

 

(1)

 

(4)

 

8

 

5

 

(83)

 

616

Income tax benefit (expense)

 

 

46

 

12

 

(1)

 

 

 

 

 

(74)

 

(17)

Net income (loss)

 

862

 

(67)

 

(46)

 

(1)

 

(1)

 

(4)

 

8

 

5

 

(157)

 

599

Less: net income loss attributable to non-controlling interests

 

471

 

(34)

 

 

 

 

 

 

 

 

437

Net (loss) income attributable to Icahn Enterprises

$

391

$

(33)

$

(46)

$

(1)

$

(1)

$

(4)

$

8

$

5

$

(157)

$

162

Supplemental information:

 

Capital expenditures

$

$

34

$

8

$

2

$

1

$

1

$

$

1

$

$

47

Depreciation and amortization

$

$

82

$

22

$

7

$

3

$

2

$

7

$

4

$

$

127

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below

Energy

Three Months Ended March 31, 

    

2022

    

2021

(in millions)

Petroleum products

$

2,150

$

1,402

Nitrogen fertilizer products

 

223

 

61

$

2,373

$

1,463

Automotive

Three Months Ended March 31, 

    

2022

    

2021

(in millions)

Automotive services

$

353

$

327

Aftermarket parts sales

 

201

 

271

$

554

$

598

Condensed Balance Sheets

March 31, 2022

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

20

$

676

$

36

$

10

$

28

$

3

$

18

$

1,369

$

2,160

Cash held at consolidated affiliated partnerships and restricted cash

 

3,699

 

7

 

17

 

 

12

 

 

 

66

 

3,801

Investments

 

7,276

 

78

 

 

 

15

 

 

 

28

 

7,397

Accounts receivable, net

 

 

353

 

110

 

84

 

10

 

29

 

18

 

 

604

Inventories, net

 

 

683

 

805

 

104

 

 

111

 

17

 

 

1,720

Property, plant and equipment, net

 

 

2,720

 

789

 

143

 

350

 

59

 

 

6

 

4,067

Goodwill and intangible assets, net

 

 

216

 

360

 

27

 

 

19

 

247

 

 

869

Other assets

 

6,178

 

277

 

495

 

104

 

107

 

22

 

5

 

23

 

7,211

Total assets

$

17,173

$

5,010

$

2,612

$

472

$

522

$

243

$

305

$

1,492

$

27,829

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

2,113

$

1,973

$

986

$

152

$

55

$

64

$

51

$

775

$

6,169

Securities sold, not yet purchased, at fair value

 

4,776

 

 

 

 

 

 

 

 

4,776

Debt

 

 

1,595

 

20

 

158

 

1

 

41

 

 

5,311

 

7,126

Total liabilities

 

6,889

 

3,568

 

1,006

 

310

 

56

 

105

 

51

 

6,086

 

18,071

Equity attributable to Icahn Enterprises

 

4,684

 

746

 

1,606

 

147

 

462

 

138

 

254

 

(4,594)

 

3,443

Equity attributable to non-controlling interests

 

5,600

 

696

 

 

15

 

4

 

 

 

 

6,315

Total equity

 

10,284

 

1,442

 

1,606

 

162

 

466

 

138

 

254

 

(4,594)

 

9,758

Total liabilities and equity

$

17,173

$

5,010

$

2,612

$

472

$

522

$

243

$

305

$

1,492

$

27,829

December 31, 2021

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

19

$

510

$

28

$

10

$

30

$

3

$

14

$

1,707

$

2,321

Cash held at consolidated affiliated partnerships and restricted cash

 

2,008

 

7

 

17

 

 

11

 

 

 

72

 

2,115

Investments

 

8,952

 

79

 

 

 

15

 

 

 

105

 

9,151

Accounts receivable, net

 

 

299

 

103

 

82

 

10

 

32

 

20

 

 

546

Inventories, net

 

 

484

 

780

 

93

 

 

106

 

15

 

 

1,478

Property, plant and equipment, net

 

 

2,735

 

786

 

147

 

351

 

60

 

 

6

 

4,085

Goodwill and intangible assets, net

 

 

221

 

362

 

27

 

 

21

 

254

 

 

885

Other assets

 

6,156

 

252

 

506

 

99

 

109

 

21

 

6

 

16

 

7,165

Total assets

$

17,135

$

4,587

$

2,582

$

458

$

526

$

243

$

309

$

1,906

$

27,746

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

2,405

$

1,579

$

981

$

146

$

49

$

71

$

50

$

90

$

5,371

Securities sold, not yet purchased, at fair value

 

5,340

 

 

 

 

 

 

 

 

5,340

Debt

 

 

1,660

 

26

 

155

 

1

 

40

 

 

5,810

 

7,692

Total liabilities

 

7,745

 

3,239

 

1,007

 

301

 

50

 

111

 

50

 

5,900

 

18,403

Equity attributable to Icahn Enterprises

 

4,271

 

686

 

1,575

 

143

 

472

 

132

 

259

 

(3,994)

 

3,544

Equity attributable to non-controlling interests

 

5,119

 

662

 

 

14

 

4

 

 

 

 

5,799

Total equity

 

9,390

 

1,348

 

1,575

 

157

 

476

 

132

 

259

 

(3,994)

 

9,343

Total liabilities and equity

$

17,135

$

4,587

$

2,582

$

458

$

526

$

243

$

309

$

1,906

$

27,746